SHANGHAI HI SILICON TECHNOLOGY CO., LTD.
SHANGHAI HI SILICON TECHNOLOGY CO., LTD.

Compliance Case of BINAP Addressing REACH Compliance Gaps & GMP Documentation Deficiencies

Table of Content [Hide]

    HiSiaddi is an innovative foreign trade service provider driven by both technology commercialization and export business. We have established a "1+2+3+4=1" service system and can supply BINAP sourced directly from well-known original manufacturers worldwide. With over a decade of market experience and technical cooperation with manufacturers, HiSiaddi possesses extensive expertise resolving product compliance issues. Below is a case study of HiSiaddi addressing BINAP compliance challenges.

    Please contact HiSiaddi customer service if you require further consultation on BINAP product compliance issues.

    1. Client Profile

    The client is a high-end pharmaceutical intermediate enterprise based in Berlin, Germany, focusing on R&D and production of chiral intermediates for anti-tumor drugs, supplying multiple top-tier European pharmaceutical companies with full FDA, EMA and GMP certification, representing a mid-to-high-end client with stringent compliance requirements. The client purchases 50 kg of pharmaceutical-grade 99.8% R-BINAP annually, previously sourcing Takasago (Japan) products before shifting to Chinese suppliers for cost reduction in 2025. After signing a 20 kg initial order, severe obstacles emerged in EU REACH compliance, GMP documentation completeness and supply chain traceability, risking cargo detention and return shipment. The client urgently entrusted HiSiaddi to resolve all compliance hurdles.

    2. Core Compliance Dilemmas (Exclusive Pain Points for Mid-to-High-End Clients)

    (1) REACH Compliance Gaps Blocking EU Market Access

    As an EU enterprise, the client is subject to mandatory REACH Regulation (EC 1907/2006): annual imports exceeding 1 ton require full REACH registration, with mandatory provision of compliant SDS (Safety Data Sheet) and SVHC (Substances of Very High Concern) full-test reports. Most Chinese manufacturers lack REACH registration, only providing Chinese MSDS without EU-recognized English SDS, SVHC full-test reports or REACH Only Representative (OR) qualifications. This leads to customs detention upon cargo arrival, with risks of return shipment and heavy fines.

    (2) Incomplete GMP Documentation Failing Pharmaceutical-Grade Access Standards

    The client’s production lines hold EMA GMP certification, requiring suppliers to provide a complete GMP document chain including factory GMP certificates, DMF (Drug Master File) for raw materials, batch traceability records, impurity traceability reports and third-party audit reports. The cooperating Chinese factory only supplied basic COA (Certificate of Analysis), lacking GMP compliance certificates, DMF files and full impurity traceability data, failing internal client quality audits and preventing raw material introduction to pharmaceutical production lines.

    (3) Broken Supply Chain Traceability Violating EU Traceability Supervision

    EU pharmaceutical regulations mandate full-chain traceability, requiring provision of raw material origin certificates, production process flowcharts, key raw material procurement vouchers, batch production records, export customs declarations and Certificates of Origin (CO). Weak traceability awareness among Chinese manufacturers prevents submission of complete production records, key raw material traceability vouchers and compliant CO documents, blocking the client’s EU supply chain filing and delaying drug market approval.

    (4) Core Client Requirements: Zero-Risk Customs Clearance, Fully Matching Documentation & Long-Term Compliance Guarantees

    Clear client demands: resolve all compliance issues within 7 days to guarantee smooth customs clearance; documentation 100% compliant with EMA and REACH standards; establish long-term compliance mechanisms to secure stable supply for the annual 50 kg order, eliminating any compliance defects that delay drug launch schedules.

    3. HiSiaddi Compliance Resolution: Four-Step Closed-Loop Solution to Fully Resolve Compliance Barriers

    HiSiaddi formed a special team consisting of REACH regulatory specialists, GMP auditors and supply chain traceability officers, developing a one-stop solution of "compliance completion + document reconstruction + traceability linkage + long-term guarantee" targeting the three core dilemmas, fully implemented within 7 days.

    (1) REACH Compliance Completion: Rapid Acquisition of EU Market Access Qualifications

    1. Secure REACH Only Representative (OR): Cooperate with German local REACH compliance institution Chemreach, completing OR authorization within 24 hours. The German institution acts as the Chinese factory’s EU-only representative to assume REACH registration and compliance responsibilities, resolving the core barrier preventing non-EU enterprises from direct registration.

    2. Compile Compliant SDS & SVHC Testing:

    o Prepare 16-section English SDS complying with EU CLP standards, supplementing BINAP physicochemical properties, hazard classification, safe operating specifications and REACH compliance statements;

    o Entrust TÜV Rheinland to conduct full SVHC 197-item testing and issue REACH-compliant test reports certifying BINAP contains no high-concern substances.

    3. Complete REACH Pre-Registration & Tonnage Declaration: Submit BINAP REACH pre-registration to ECHA via the OR, declaring annual export volume of 50 kg (≤1 ton, exempt from full formal registration) and obtaining a REACH pre-registration number to satisfy minimum EU customs clearance compliance requirements.

    (2) GMP Documentation Reconstruction: Build Pharmaceutical-Grade Compliance Document Chain

    1. Factory GMP Compliance Certification: Coordinate partner manufacturers to complete GMP compliance audit via China Chamber of Commerce for Import and Export of Medicines and Health Products within 3 days, issuing EMA-aligned GMP certificates verifying factory production environments and quality control meet pharmaceutical-grade standards.

    2. Compile DMF & Full Impurity Traceability Reports:

    o Assist manufacturers in organizing production processes, quality standards and impurity control protocols to prepare dedicated BINAP DMF files for client filing;

    o Generate full impurity traceability reports based on GC-MS and HPLC test data, clarifying sources and control measures for heavy metals (≤0.5 ppm), residual solvents and chiral impurities in line with USP pharmaceutical standards.

    3. Supplement Batch Traceability & Third-Party Audit Reports: Consolidate batch production records, raw material procurement vouchers, equipment calibration records and quality control records to form complete batch traceability files; entrust SGS to conduct third-party factory audits and issue audit reports meeting client internal quality review requirements.

    (3) Supply Chain Traceability Linkage: Achieve End-to-End Traceability

    1. Apply for Compliant Certificate of Origin (CO): Assist manufacturers to apply for general CO from China Council for the Promotion of International Trade, marking BINAP origin, manufacturer and HS code (29319000) to verify Chinese origin and satisfy EU tariff and traceability requirements.

    2. Establish Full-Chain Traceability Archives: Integrate raw material procurement contracts, production process flowcharts, batch COA reports, SDS reports, export customs declarations and CO certificates into electronic traceability archives, enabling clients to query full-process information via batch numbers in compliance with EU pharmaceutical traceability supervision.

    3. Accurate HS Code Classification: Confirm BINAP HS code 29319000 (Organophosphorus Compounds) to eliminate customs clearance delays from misclassification, simultaneously providing classification explanations for client customs filing.

    (4) Risk Mitigation & Long-Term Compliance Guarantees

    1. Full Customs Clearance Support: Provide a complete customs clearance document checklist (SDS, SVHC reports, GMP certificates, COA, CO, customs declarations) and assist the client with EU customs filing, enabling smooth clearance within 2 days without detention fees or penalties.

    2. Establish Long-Term Compliance Mechanism: Sign a Long-Term Compliance Guarantee Agreement with the client, committing to:

    o Annual updates of REACH compliance files and SVHC test reports;

    o Quarterly reviews of factory GMP compliance status;

    o Real-time synchronization of EU regulatory updates with proactive compliance strategy adjustments;

    o 24-hour compliance consulting service for rapid response to compliance issues.

    4. Implementation Outcomes: Smooth Customs Clearance, Fully Approved Documentation & Deepened Long-Term Cooperation

    (1) Customs Clearance & Production Verification

    · The initial 20 kg BINAP cargo cleared customs without delay, fines or detention;

    · Full client testing results: purity 99.85%, ee value 99.68%, heavy metals 0.4 ppm, all impurities qualified. GMP documentation passed EMA audit 100%, raw materials successfully introduced to anti-tumor drug production lines with product quality matching Japanese imported equivalents.

    (2) Client Feedback

    The client’s quality director commented: "Compliance is the lifeline for high-end pharmaceutical enterprises. HiSiaddi accurately resolved three core compliance hurdles covering REACH, GMP and traceability, completing a closed compliance loop within 7 days with documentation fully aligned with EU standards, saving us from massive economic losses and drug launch delays. Professional, efficient and reliable, HiSiaddi is a long-term compliance partner we can fully trust."

    (3) Deepened Cooperation

    The client awarded HiSiaddi full agency rights for its annual 50 kg BINAP order, entrusting additional high-end customization demands including S-BINAP and sulfonated BINAP to HiSiaddi for integrated services covering procurement, quality control and traceability alongside compliance support. A 3-year framework cooperation agreement was signed, stipulating all future Chinese raw material procurement shall undergo compliance review by HiSiaddi.

    5. Case Summary

    Core compliance pain point for mid-to-high-end clients: Missing REACH registration, incomplete GMP documentation and broken supply chain traceability. Compliance directly determines market access eligibility for EU entry and pharmaceutical production applicability, ranking above pricing as the primary procurement decision factor. HiSiaddi Core Value: Beyond simple cargo trading, HiSiaddi acts as cross-border compliance specialists with expertise covering REACH regulations, GMP auditing and supply chain traceability, capable of rapid resource integration to deliver one-stop compliance solutions and mitigate client compliance risks. Core Compliance Service Logic: For EU pharmaceutical-grade clients, precise alignment with REACH, EMA and GMP three-in-one compliance systems is mandatory, complemented by complete SDS, SVHC reports, GMP certificates, DMF and traceability files, alongside long-term compliance guarantee mechanisms to fully satisfy mid-to-high-end client demands and secure lasting partnerships.

    Please contact HiSiaddi customer service if you require further consultation on BINAP product compliance issues.


    References
    We use cookies to optimise and personalise your experience, but you can choose to opt out of non-essential cookies.
    To find out more, read our Privacy Policy
    Reject All
    Accept All